116 related articles for article (PubMed ID: 35599471)
1. Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer.
Kim JH; Youn Y; Lee JC; Kim J; Ryu JK; Hwang JH
Cancer Biomark; 2022; 34(4):647-659. PubMed ID: 35599471
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
Han G; Zhang X; Liu P; Yu Q; Li Z; Yu Q; Wei X
Int J Oncol; 2018 Nov; 53(5):2056-2066. PubMed ID: 30132513
[TBL] [Abstract][Full Text] [Related]
3. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer.
Wang K; Hao Z; Fu X; Li W; Jiao A; Hua X
Mol Cell Biochem; 2022 Jul; 477(7):1947-1957. PubMed ID: 35362843
[TBL] [Abstract][Full Text] [Related]
4. Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc.
Zhang M; Zhang L; Zhou M; Wang E; Meng B; Li Q; Wang X; Wang Y; Li Q
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36416310
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway.
Zhang Z; Ning M; Li L; Li Z; Wang Y; Zhao J
Oncol Lett; 2023 Jun; 25(6):242. PubMed ID: 37153049
[TBL] [Abstract][Full Text] [Related]
6. ASF1B promotes cervical cancer progression through stabilization of CDK9.
Liu X; Song J; Zhang Y; Wang H; Sun H; Feng X; Hou M; Chen G; Tang Q; Ji M
Cell Death Dis; 2020 Aug; 11(8):705. PubMed ID: 32848135
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-520d-3p suppresses melanoma cells proliferation by inhibiting the anti-silencing function 1B histone chaperone.
Shi X; Xu X; Shi N; Chen Y; Fu M
Bioengineered; 2021 Dec; 12(2):10703-10715. PubMed ID: 34872448
[TBL] [Abstract][Full Text] [Related]
8. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma.
Jiangqiao Z; Tao Q; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z; Tianyu W
Biochem Biophys Res Commun; 2019 Mar; 511(1):165-172. PubMed ID: 30777326
[TBL] [Abstract][Full Text] [Related]
9. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway.
Wang W; Xiao L; Pan D; Hu L
Neoplasma; 2022 Mar; 69(2):361-369. PubMed ID: 35103478
[TBL] [Abstract][Full Text] [Related]
10. The interaction between
Zhang Z; Liu S
Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
Wang L; Yang X; Zhou F; Sun X; Li S
Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
[TBL] [Abstract][Full Text] [Related]
12. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.
Ouyang X; Lv L; Zhao Y; Zhang F; Hu Q; Li Z; Zhu D; Li L
Front Oncol; 2021; 11():801506. PubMed ID: 35087760
[TBL] [Abstract][Full Text] [Related]
13. Carcinogenic Role and Clinical Significance of Histone H3-H4 Chaperone Anti-silencing Function 1 B (ASF1B) in Lung Adenocarcinoma.
Song C; Song Y; Wan X; Zhao Z; Geng Q
J Cancer; 2024; 15(1):218-231. PubMed ID: 38164276
[TBL] [Abstract][Full Text] [Related]
14. Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.
Paul PK; Rabaglia ME; Wang CY; Stapleton DS; Leng N; Kendziorski C; Lewis PW; Keller MP; Attie AD
Cell Cycle; 2016 Dec; 15(23):3191-3202. PubMed ID: 27753532
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells.
Kong F; Liu X; Zhou Y; Hou X; He J; Li Q; Miao X; Yang L
Int J Biochem Cell Biol; 2020 May; 122():105731. PubMed ID: 32097728
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
Hu X; Zhu H; Zhang X; He X; Xu X
Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
[TBL] [Abstract][Full Text] [Related]
17. ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer.
Chen C; Bao H; Lin W; Chen X; Huang Y; Wang H; Yang Y; Liu J; Lv X; Teng L
J Cancer; 2022; 13(6):1985-2000. PubMed ID: 35399734
[TBL] [Abstract][Full Text] [Related]
18. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
19. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.
Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H
Front Genet; 2022; 13():842351. PubMed ID: 35360875
[No Abstract] [Full Text] [Related]
20. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.
Sahu RP; Batra S; Srivastava SK
Br J Cancer; 2009 May; 100(9):1425-33. PubMed ID: 19401701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]